PROTHERA INC has a total of 46 patent applications. It decreased the IP activity by 100.0%. Its first patent ever was published in 2002. It filed its patents most often in United States, Canada and EPO (European Patent Office). Its main competitors in its focus markets foods and drinks, pharmaceuticals and environmental technology are SYNBIOTICS AB, WINCLOVE HOLDING B V and BIOFERMIN PHARMA.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 10 | |
#2 | Canada | 8 | |
#3 | EPO (European Patent Office) | 8 | |
#4 | Republic of Korea | 5 | |
#5 | Australia | 4 | |
#6 | Japan | 4 | |
#7 | WIPO (World Intellectual Property Organization) | 4 | |
#8 | China | 3 |
# | Industry | |
---|---|---|
#1 | Foods and drinks | |
#2 | Pharmaceuticals | |
#3 | Environmental technology | |
#4 | Measurement | |
#5 | Biotechnology |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Therapeutic chemical compounds | |
#3 | Foods | |
#4 | Special foods | |
#5 | Climate change adaptation technologies | |
#6 | Special bacteria in foodstuffs | |
#7 | Measuring microorganism processes | |
#8 | Analysing materials | |
#9 | Enzymes | |
#10 | Food shaping |
# | Name | Total Patents |
---|---|---|
#1 | Olmstead Stephen F | 24 |
#2 | Olmstead Stephen Francis | 14 |
#3 | Stephen F Olmstead | 4 |
#4 | Houston Devin B | 4 |
Publication | Filing date | Title |
---|---|---|
KR20210013352A | Probiotic compositions and methods for the treatment of obesity and obesity-related conditions | |
AU2012267516A1 | Pharmaceutical compositions containing pediococcus and methods for reducing the symptoms of gastroenterological syndromes | |
KR20140053949A | Pharmaceutical compositions containing proteases and methods for the treatment of lysosomal storage diseases | |
CA2780756A1 | Compositions and methods comprising serratia peptidase for inhibition and treatment of biofilms related to certain conditions | |
US2011091431A1 | Compositions and methods comprising pediococcus for reducing at least one symptom associated with autism spectrum disease in a person diagnosed with an autism spectrum disease | |
US2009202516A1 | Inhibition and treatment of gastrointestinal biofilms | |
US2007092501A1 | Compositions and methods relating to reduction of symptoms of autism | |
US6808708B2 | Compositions and methods relating to reduction of symptoms of autism |